{
    "symbol": "APX.TO",
    "slug": "apx-to",
    "display_name": "APX.TO",
    "category": "stocks",
    "region": "CA",
    "description": null,
    "url": "https://finscans.com/asset/apx-to",
    "lang": "en",
    "as_of": "2026-06-28T04:08:22+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 1,
        "bearish": 0,
        "neutral": 0,
        "explicit": 1,
        "inferred": 0,
        "avg_impact": 7,
        "avg_confidence": 75,
        "last_signal_at": "2026-06-10 03:47:48",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "Apotex IPO priced at top of range",
            "count": 1
        },
        {
            "text": "Strong investor demand for pharmaceutical sector",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "General market downturn could dampen listing gains",
            "count": 1
        },
        {
            "text": "Generic drug pricing pressures in Canada",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-06-10 03:47:48",
            "sentiment": "Bullish",
            "impact_score": 7,
            "confidence_score": 75,
            "mention_type": "explicit",
            "timeframe": "short-term",
            "region": "CA",
            "reasoning": "Apotex priced its Canadian IPO at the top of the range to raise $932 million, signaling strong investor demand. The pricing values the generic drugmaker above initial estimates, reflecting confidence in its growth prospects and the broader pharmaceutical sector. The successful IPO could set a positive tone for Apotex shares upon listing.",
            "article": {
                "title": "Apotex Prices Canada IPO at Top, Raising $932 Million",
                "url": "https://finscans.com/news/apotex-prices-canada-ipo-at-top-raising-932-million"
            }
        }
    ]
}